Due to its high specificity, 2HG is a valuable imaging biomarker for diagnosing,5,6 monitoring, assessing tumor burden,7 treatment response,8,9 and pharmacodynamics of targeted therapy in mutant IDH1 glioma.10 This evidence concerns the gene IDH1 and glioma.